Logo (WIPO, 09/28/2022)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark was filed as Figurative mark on 09/28/2022 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models #Natural phenomena #Parts of the human body, skeletons, skulls #Lines, bands #Colours #Atomic models, molecular models, representations of human, animal or vegetal cells #Flames #Other natural phenomena not classified in other divisions or categories, soil, aurora borealis (Northern Lights) #Other parts of the human body, DNA band, cells, brains, sperms, hair roots (also 2.9.12) #Oblique lines or bands #Five colours and over
| Trademark form | Figurative mark |
| File reference | 1695756 |
| Countries | 
|
| Base trademark |
No. 2022036292,
March 30, 2022
|
| Application date | September 28, 2022 |
| Expiration date | September 28, 2032 |
Trademark owner
3-4-10, Shinsuna,
Koto-ku
JP
Koto-ku
JP
Trademark representatives
Markstone IP Attorneys, Verty Nakano 202,
29-10, Honcho 3-chome,
JP
goods and services
01
Industrial chemicals; chemical preparations for scientific
purposes; diagnostic reagents for scientific or research
use; chemicals for use in the manufacture of
pharmaceuticals; chemicals for use in the manufacture of
radiopharmaceuticals; radioactive elements for scientific
purposes; isotopes for industrial purposes; peptide
substrates for scientific purposes; peptide for use in the
manufacture of pharmaceuticals; chelating agents for use in
the manufacture of pharmaceuticals; polypeptides for
scientific purposes; antibodies for scientific purposes,
other than for medical or veterinary use; chelate compound;
organic chelating agents; metal chelating agents
05
Pharmaceuticals; reagents for medical purposes; medical
diagnostic reagents; radioactive substances for medical
purposes; isotopes for medical purposes; radioisotope
markers for therapeutic or diagnostic use; radioactive
pharmaceutical preparations for in vivo diagnostics or
therapeutic use; synthetic peptides for pharmaceutical
purposes; pharmaceuticals consisting of antibodies;
pharmaceuticals consisting of antibody fragments;
pharmaceuticals consisting of antibody derivatives;
antibodies for medical purposes
40
Custom manufacture of pharmaceuticals; custom manufacture of
investigational new drug; custom manufacture of
radiopharmaceuticals; custom synthesis of labeled compound;
custom manufacture of peptides; custom manufacture of
antibodies; custom manufacture of proteins; custom protein
modification; custom antibody modification; custom
extraction, refining or synthesis of pharmaceuticals and
veterinary preparations; custom peptide synthesis services;
custom refining, synthesis or manufacture of pharmaceuticals
consisting of antibodies; custom refining, synthesis or
manufacture of pharmaceuticals consisting of antibody
fragments; custom refining, synthesis or manufacture of
pharmaceuticals consisting of antibody derivatives; custom
radioactive labeling of antibodies; custom radioactive
labeling of antibody fragments; custom radioactive labeling
of antibody derivatives; custom radioactive labeling of
peptides
42
Research and development of medicines; testing, inspection
or research services in the fields of pharmaceuticals;
advisory, consultancy and providing information relating to
testing, inspection or research services in the fields of
pharmaceuticals; development of pharmaceuticals; advisory,
consultancy and providing information relating to
development of pharmaceuticals; conducting clinical trials
for pharmaceuticals; advisory, consultancy and providing
information relating to clinical trials for pharmaceuticals;
research and development of radiopharmaceuticals;
development of radiopharmaceuticals; advisory, consultancy
and providing information relating to development of
radiopharmaceuticals; research and development services
relating to peptides; research and development services in
the field of antibodies; research and development services
relating to peptide labeling by radioactive substances;
research and development services relating to antibody
labeling by radioactive substances
45
Granting of licenses to others for the use of intellectual
property; exploitation of industrial property rights [legal
services]
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 6, 2023 | 2023/15 Gaz | EM | Rejection |
| February 15, 2023 | 2023/7 Gaz | US | Rejection |
| February 9, 2023 | 2023/6 Gaz | GB | Rejection |
| September 28, 2022 | 2022/44 Gaz | JP | Registration |
ID: 141695756